PROK as of Nov 3 · 17:36 ET
PROKNasdaqBiological Products, (No Diagnostic Substances)

Prokidney Corp. · Brief

Next report

6 days

Nov 9 · after closeest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±58.0%▼−4.73%×0.08
quarterimplied−60%0+60%realized×
Q2 FY26±58.0%▼−4.73%×0.08
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2

70managers reporting a position in the latest quarterly filings hold widespread stakes13F · Jun 30 '26
+14.01%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

11managers whose positions together make up four fifths of the reported value dominate holdings13F · Jun 30 '26
5 of 23of the largest reporting managers cut their stake in the latest quarter reducing confidence13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

PROK report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 298-KMaterial agreement: Open Market Sale Agreement SM with Jefferies LLC.Source
Oct 27impliedImplied move: ±58.9% into Nov 9 earnings (Oct 27 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.